Hypertrophic Cardiomyopathy

Autosomal dominant genetic disorder characterised by left ventricular hypertrophy (LVH), impaired diastolic filling, and abnormalities of the mitral valve; it is the most common cause of sudden cardiac death in young people

Aetiology

  • Genetic - 60% of patients have an autosomal dominant mutation in sarcomeric genes

Pathophysiology

  • Portion of the heart becomes thickened, resulting in diastolic dysfunction - heart is unable to fully relax
  • Eventually leads to outflow obstruction

Clinical presentation

  • Many cases are asymptomatic and are detected by family screening of an affected individual or by a routine ECG examination
  • Sudden death occurs at any age but the highest rates occur in adolescents or young adults
  • When present, symptoms include dyspnoea, AF, syncope, palpitations and angina

Investigations

  • ECG changes - LV hypertrophy, ST and T wave changes, abnormal Q waves
  • Echocardiography is usually diagnostic

Management

  • Patients with 2 or more risk factors for sudden cardiac death should be assessed for ICD insertion
    • RF include massive LH hypertrophy, prior unexplained syncope and family history of sudden cardiac death
  • Chest pain and dyspnoea are treated with beta-blockers and verapamil (alone or in combination)